MDMA-assisted psychotherapy for PTSD: Growing evidence for memory effects mediating treatment efficacy.
Mesud Sarmanlu, Kim P C Kuypers, Patrick Vizeli, Timo L Kvamme
Progress in neuro-psychopharmacology & biological psychiatry January 10, 2024 DOI: 10.1016/j.pnpbp.2023.110843 via PubMed
Summary
AI-generated from the abstractMDMA-assisted psychotherapy for PTSD shows promising safety and efficacy in clinical trials, but its underlying mechanisms are not well understood. This review examines preclinical and clinical evidence suggesting that MDMA's effects on memory processes—specifically fear extinction and fear reconsolidation—may contribute to the treatment's success. The authors integrate findings from cognitive psychology and psychopharmacology to support this view and provide recommendations for future research.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Topics | MDMA PTSD |
| Keywords | Memory Psychotherapy Trauma |
| Citations | 17 |
| Key finding | The efficacy of MDMA-assisted psychotherapy for PTSD may be influenced by MDMA's effects on fear extinction and fear reconsolidation. |
Abstract
The application of MDMA in conjunction with psychotherapy has in recent years seen a resurgence of clinical, scientific, and public interest in the treatment of posttraumatic stress disorder (PTSD). Clinical trials have shown promising safety and efficacy, but the mechanisms underlying this treatment form remain largely unestablished. This article explores recent preclinical and clinical evidence suggesting that the treatment's efficacy may be influenced by the mnemonic effects of MDMA. We review data on the effects of MDMA on fear extinction and fear reconsolidation and the utility of these processes for PTSD treatment. We corroborate our findings by incorporating research from cognitive psychology and psychopharmacology and offer recommendations for future research.